Staining for argyrophilic nucleolar organizer regions (AgNORs) has proven useful in differentiating recurrent or malignant neoplasms from less aggressive or benign ones. We applied this stain to benign and malignant smooth muscle tumors and to hyperplastic and carcinomatous lesions in the urinary bladder of dogs in an effort to determine its utility in diagnostic situations. The stain was simply performed, and the results were repeatable for different staining intervals and between staining batches. For smooth muscle tumors, enumeration of AgNORs in 100 nuclei was about as efficient as mitotic index in correctly categorizing histologically benign and malignant neoplasms. The mean number of AgNORs/100 nuclei for leiomyomas was significantly less than that obtained for leiomyosarcomas and significantly greater than that obtained for normal smooth muscle. Counts for smooth muscle tumors correlated with the mitotic indexes. Counts by an individual observer were repeated without introducing significant variation, but there was variability between observers, particularly in AgNOR counts for leiomyosarcomas. AgNORs were not useful in separating hyperplastic or polypoid cystitis from transitional cell carcinoma, misclassifying both. Mean AgNOR counts for these 2 conditions did not differ at the 5% level of significance; mitotic index was more efficient at separating the 2 conditions. There was no correlation between mitotic index and AgNOR in urinary tract mucosal specimens. This easily prepared stain may be useful in separating benign and malignant smooth muscle tumors, although AgNORs were less contributory to diagnosing mucosal lesions of the urinary bladder of dogs.
Nucleolar organizer regions are focal aggregates of intranuclear nonhistone proteins that are associated with potential sites of ribosomal DNA transcription. 18 These proteins are easily localized by virtue of their argyrophilia, hence the acronym AgNOR (argyrophilic nucleolar organizing region). The mean number of AgNORs per nucleus accurately correlates with mitotic rate in tumor cell lines 21 and AgNOR counts may thus provide an indirect measurement of mitotic rate in surgical specimens that is free of the bias produced by postexcisional handling of tissue. The stained complex corresponds ultrastructurally to the binding sites of RNA polymerase 1 and associated proteins regulating transcription and posttranslational modification of ribosomal RNA. 6 Measurement and enumeration of AgNORs have been useful in prognosticating the behavior of a variety of neoplasms of humans, particularly in instances where mitotic rate is a poor determinant of eventual recurrence of metastasis. 1, 18 AgNORs have been less useful in epithelial tumors, in which there is a relatively high mitotic rate in the cell type of origin 8 as compared with sarcomas. However, AgNORs have recently been utilized to successfully forecast the probability of canine mammary tumor recurrence and metastasis 3 and to predict the probability of mast cell recurrence. 2 Staining of these structures might also be of use in locating the border between neoplastic and normal tissue at the margins of surgical specimens.
The purpose of this study was to test the usefulness of AgNOR counts in diagnostic veterinary pathology. We chose 2 different problems. We examined the ability of AgNOR counts, as compared with mitotic indexes, to discriminate among normal intestinal smooth muscle, benign smooth muscle tumors (leiomyomas, leiomyofibromas, and fibroleiomyomas) and leiomyosarcomas in dogs and also tested the ability of these 2 parameters to distinguish normal and hyperplastic mucosa of the canine urinary bladder mucosa from transitional cell carcinoma. Retrospectively gathered cases with known histological diagnoses from the Veterinary Medical Diagnostic Laboratory were used in the study.
Materials and methods
Tissues. Cases were retrieved according to diagnosis from the computer records of the University of Missouri Veterinary Medical Diagnostic Laboratory. All appropriate cases submitted to the laboratory between November 1, 1986, and June 30, 1992, were used for study. Tissues had been fixed by immersion in 10% neutral buffered formalin and embedded in paraffin by standard methods. Most of the tissues examined had been fixed for 2-7 days before embedding. Hematoxylin and eosin (HE)-stained sections were examined to locate representative areas for staining, confirm the diagnosis, and determine the mitotic index. Normal smooth muscle and urinary bladder mucosa came from portions of the specimens that were well away from areas of neoplasia or hyperplasia.
Staining of NORs. AgNOR staining utilized a one-step silver staining procedure. 17 Sections 3-5 µm thick were deparaffinized and rehydrated prior to staining. Staining solution was prepared by adding 1 volume of gelatin (2 g/dl) in 1% formic acid to 2 volumes aqueous silver nitrate (50 g/dl). After staining at room temperature in the dark, silver colloid was washed from slides with deionized distilled water and tissues were dehydrated through alcohols, cleared with xylene, and coverslipped. No counterstain was applied.
AgNORs were defined as dark, argyrophilic, round, oval, or bar-shaped structures within the cell nucleus or as clusters of small connected dots. 7 A yellow-green filter (Wratten number 11) was used to enhance contrast and reduce eye strain. Both intra-and extranucleolar AgNORs were counted in a plane of focus that revealed the nuclear membrane, using the oil immersion objective (N.A. 160, field diameter 200 µm, as measured by stage micrometer). AgNORs were counted in 100 nuclei in each specimen. In specimens with a high nuclear axis ratio, tissue oriented so that the long nuclear axes were visible was used for counts.
All nuclei were counted in appropriate areas; the first field was selected randomly, and additional appropriate fields were found by pursuing a battlement pattern across the slide. Counting was done without knowledge of the diagnosis of the case.
Mitoses were counted in HE-stained tissues, using a 40x objective (N.A. = 160, field width = 510 µm), following a similar pattern, and using established criteria for distinguishing mitotic figures. 22 Staining utility. Initial attempts at staining and enumerating AgNORs used hamster livers. Four liver specimens with variable AgNOR densities per nucleus were counted using replicate sections stained for 30 or 60 min by the above technique. Sections stained for 30 or 60 min ranged from too pale to excessive background staining but gave similar results when counts were done. Forty-five minutes was selected as an optimal staining time. Next, 2 other liver specimens were stained on 3 separate occasions using different batches of stain, and AgNOR counts were performed by the same observer.
Examination of patient tissues. Specimens of normal smooth muscle (n = 15), leiomyomas (n = 18), and leiomyosarcomas (n = 7) were first examined by 1 observer (GCJ) on 3 separate occasions. Analysis of variance revealed no significant variability associated with repeat measurements as compared with that between specimens (5% level). No effort was made to evaluate identical areas of sample when replicate counts were done. Two other observers also performed AgNOR counts on these samples (MAM, JAR). Comparisons between groups were made using the average of 1 set of observations from each observer. Mitotic counts for both smooth muscle and urinary mucosal lesions and AgNOR counts on urinary bladder mucosal lesions (12 samples of normal bladder mucosa, 12 transitional cell carcinomas, and 7 cases of hyperplastic or polypoid cystitis) were made by 1 observer only (GCJ).
Statistics. Variability between and within sample groups was compared by analysis of variance (ANOVA), and mean values for various groups were compared using Student's t-test. All calculations were performed by Minitab software, version 2.0. a Predictive values, specificity, sensitivity, and efficiency of tissue categorization were calculated according to formulae listed in the footnotes of Table 2 
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Results
Staining variability. The 30-minute staining period yielded sections with low contrast between the Ag-NORs and adjacent nucleoplasm ( Fig. 1 A) , but 60 minutes of staining sometimes made it difficult to distinguish individual AgNORs and produced excessive stain precipitate on the section (Fig. 1B ). To determine whether staining time affected quantitation of AgNOR numbers, mean AgNORs were determined by 1 observer on 3 separate occasions. Means of these 3 observations are shown in Table 1A . Mean counts for each specimen are similar between the 2 staining times. Staining interval did not result in significant variation between counts for a given specimen as compared with counts between specimens with a 2-way ANOVA. On the basis of personal preference, an intermediate staining time of 45 minutes was chosen for subsequent use.
Additional specimens were evaluated by staining tissues from 2 blocks for 45 minutes with 3 separately mixed batches of stain. Four individual AgNOR determinations for each slide stained in each batch are listed in Table 1B . The 2-way ANOVA detected no significant impact of different batches of stain on mean AgNOR counts.
AgNOR counts and mitotic index in smooth muscle tumors. AgNORs were counted in 15 samples of normal intestinal smooth muscle, 18 benign smooth muscle tumors (leiomyomas and leiomyofibromas), and 12 leiomyosarcomas. Tumors were of enteric, reproductive tract, and urinary tract origins. The initial diagnosis was reviewed by examining HE-stained sections. In 6 of 12 instances, the malignant potential of leiomyosarcomas was manifest by involvement of multiple organs at the time of biopsy or by subsequent necropsy examination. Of dogs with benign smooth muscle tumors, 6 had leiomyomas and 12 had tumors of mixed fibroblastic and smooth muscle origin (leiomyofibromas). Patients with benign tumors were overwhelmingly female (17 of 18), a result of the numerous vaginal tumors in this group (12 of 18 tumors), but the sexes were more evenly represented in dogs with malignant tumors (6/12 were female). Dogs with malignant tumors were significantly older than those with benign neoplasms (11.5 ± 2.1 vs. 9.1 ± 3.0 years; P = 0.02, t-test).
AgNOR staining of benign and malignant smooth muscle tumors differed in pattern. Although benign tumors usually had a few relatively large and discrete AgNORs, often located within nucleoli ( Fig. 2A) , malignant tumors had more numerous foci of various sizes, which occurred both within and outside these structures (Fig. 2B ).
The number of AgNORs per nucleus, mean values of 1 set of observations by 3 observers, and the mitotic indexes of benign and malignant smooth muscle tumors are compared in Fig. 3 . Values for each specimen and the means for each group (horizontal bars) are compared with each other and, for AgNOR, in relationship to the 95% confidence interval (CI) for counts on normal smooth muscle (shaded region, Fig. 3A ; range, 1.30-1.59 AgNOR/nucleus; ± SD = 1.44 ± 0.26). Although there was overlap between values for benign smooth muscle tumors (open circles) and those for normal tissue, the mean AgNOR concentration for benign tumors (1.98 ± 0.30, 95% CI = 1.78-2.08) was significantly greater than that for normal tissue (P < 0.01, t-test). Mean values for benign smooth muscle tumors dominated by fibromatous differentiation were slightly lower than those for tumors in which smooth muscle predominated (1.81 ± 0.28 vs. 2.01 ± 0.29), but the differences were not significant (data not shown).
Malignant tumors averaged 2.92 ± 0.59 AgNORs/ nucleus (95% CI = 2.50-3.35). The means of benign and malignant tumor populations were significantly different (P = 0.004, t-test).
The mitotic index also separated benign and malignant smooth muscle tumors, with little overlap between the two categories (Fig. 3B) . The mitotic index for benign tumors averaged 0.05 ± 0.06 (95% CI = 0.02-0.09), whereas that for malignant tumors averaged 1.65 ± 1.31 (95% CI = 0.81-2.48). The 2 groups were separated by t-tests at 0.002. Mitoses were not observed in normal smooth muscle.
The mitotic index correlated fairly well with AgNOR number, with a correlation coefficient of 0.72 between the 2 values for benign and malignant tumors combined, suggesting that AgNOR is a good estimator of proliferative potential and behavior of smooth muscle neoplasms.
The ability to correctly classify individual tumors in determining the prognosis is also important for the AgNOR technique to be useful. Data in Table 2 demonstrate the efficacy of tumor classification using AgNOR counts or mitotic index as the sole diagnostic criterion for differentiating benign tumors from leiomyosarcoma, using each observer's lower 99% CI for leiomyosarcoma as the separation between the 2 groups.
Measurement results for individual specimens were classified as true negative (histologically benign tumors correctly classified as benign by the test), false negative (malignant tumors incorrectly classified as benign), true positive (correctly classified malignant tumors), and false positive (benign tumors incorrectly classified as malignant). The 99% lower CI for the malignant group was chosen to separate the 2 groups in each instance to discourage the incorrect diagnosis of malignant tumors as benign as much as possible. From these data, the predictive ability of AgNOR counts and mitotic dexes for malignancy, nonmalignancy, specificity, sensitivity, and efficiency of testing were calculated (see lower part and footnotes of Table 2 ).
Overall, AgNOR enumeration was similar to mitotic index in the efficiency with which it discriminated benign from malignant tumors, although there was some variation among observers. The overall ability of AgNOR to correctly classify benign and malignant lesions (efficiency) was 83.3%, and the efficiency of the mitotic index was 96.6%. AgNOR was slightly less specific (missed more malignant tumors) than was the mitotic index (89% vs. 92%) and overclassified benign tumors as malignant (sensitivity of 75% vs. 91.2%).
Significant variability was noted among measurements reported by individual observers. This variability was minimal for benign tumors (ANOVA, F = 0.47, P = 0.63), and hence the predictive ability for benignancy and the sensitivity were fairly uniform.
Measurements for malignant tumors varied greatly among observers (ANOVA, F = 6.89, P = 0.003), and thus the predictive ability of malignancy and the specificity of the test were low. Only 1 observer counted the mitotic indexes. There was generally good agreement between the mean AgNOR predictions and mitotic index prediction by observer 1, although sensitivity was still reduced for AgNOR counts as opposed to mitotic index. cell carcinoma). Most (6/9) patients with hyperplastic lesions were male dogs, whereas only 3/11 patients with transitional carcinomas were males (for 1 patient, the sex was not recorded).
AgNOR stains for predicting behavior of urinary bladder lesions. The diagnosis of tumors in small urinary bladder biopsies is often difficult for pathologists, because specimen orientation and tissue sampling may make it difficult to determine the extent of invasion. Thus, we examined 7 hyperplastic lesions of the canine urinary bladder mucosa (hyperplastic or polypoid cystitis), comparing them with 12 specimens of normal urinary mucosa and 12 transitional cell carcinomas.
AgNOR counts were made in 3 different areas of each specimen by 1 observer, and this procedure was repeated 3 times, giving a total of 9 counts per specimen, averaged as 1 value. A 2-way ANOVA of these repeated measurements prior to averaging revealed a large amount of variability both between individual transitional cell carcinomas (F = 33.1, P = 0.00 1) and between repeat measurements on individual carcinomas (F = 2.68, P = 0.10). Similar variation between measurements on individual samples was not observed between counts done on hyperplastic lesions of the bladder mucosa or normal urothelium. There was significant variability among the samples of hyperplastic mucosa, however (F = 12.1, P = 0.001). Patients with carcinoma were significantly older than Figure 4A illustrates the distribution of mean counts those with inflammatory lesions (mean: 5.8. years of of 1 set of observations for the various samples of age for hyperplasia vs. 11.9 years of age for transitional hyperplastic and carcinomatous lesions, relative to the Table 3 . AgNOR staining as a predictor of malignant potential in canine urinary tract mucosal lesions. cross-hatched 95% confidence interval for normal bladder mucosa ± SD = 1.64 ± 0.29, 95% CI = 1.45-1.84). Both hyperplastic and neoplastic lesions had significantly increased AgNOR counts, relative to normal bladder. A wide range of counts is present in both pathologic conditions, with considerable overlap. The mean value for neoplastic urothelium (3.38 ±t 0.81) was greater than that for hyperplasia (2.60 ± 0.94), but only at the 0.28 level of probability (t-test). Figure 4B illustrates the mitotic indexes of the 2 groups. The ranges of normal and hyperplastic bladder mucosa are virtually identical (0.16 ± 0.18 and 0.15 ± 0.16, respectively). In contrast to AgNOR measurements, the mean mitotic index of transitional cell carcinomas greatly exceeds that of either comparison group ± SD = 1.72 ± 0.89, P = 0.0001). The correlation between mitotic index and AgNOR numbers was poor for all urinary tract specimens (R = 0.25, data not shown), particularly for transitional cell carcinomas (R = 0.00), but the 2 were moderately correlated for inflammatory conditions (R = 0.65). With this much overlap between hyperplastic and neoplastic lesions of the urinary bladder, AgNOR counts were not useful in distinguishing the 2 conditions nor did they correlate with mitotic rate.
The predictability of AgNOR in classifying urinary bladder specimens is presented in Table 3 . The lower 99% confidence limit for carcinomas was used for the division between the 2 groups. With this conservative estimator, AgNOR counts could correctly classify only perplasia as tumors (only 42.9% of hyperplasia were 75% of transitional cell carcinomas predicted to not recur). Both specificity and sensitivity (prediction of recurrence), and they were also prone to misclassify hy-There were instances where the discrepancy between AgNOR numbers and behavior was particularly obvious. Figure 5A shows invasion of the adjacent connective tissue by a transitional cell carcinoma, with the inset showing relatively few large AgNORs in these invasive areas. Figure 5B shows the inverse situation in which the noninvasive transitional epithelium of polypoid cystitis contains numerous and small Ag-NORs.
In our study, the mitotic index offered a reasonable if imperfect separation of hyperplastic and malignant urothelial lesions, but AgNOR counts were not useful in this regard.
Discussion
This study demonstrated that AgNOR counts are useful in a diagnostic setting for separating benign and malignant neoplasms of smooth muscle but that they are less useful in separating hyperplastic inflammatory lesions of the urinary bladder mucosa from transitional cell carcinoma. Direct enumeration of AgNORs rather than image analysis was used to make observations because such methods are more easily adapted to. a diagnostic setting. For the same reason, neither the area of AgNORs relative to total nuclear area nor the mean AgNOR area were measured, although such measurements have been found useful in diagnosis. 18 The specimens used in our case series were typical of canine smooth muscle and urinary bladder mucosal tumors muscle reported min other series. 4, 12, 16 Benign smooth stomach, or bladder, and leiomyosarcomas arose pri-tumors arose in the-female. genital tract, skin, marily in the intestine, mesentery, and spleen. A ratio are low.. Mitotic index, on the other hand, better separated the 2 categories of specimens and was 84% ef-of 1 leiomyosarcoma to 11 benign vaginal smooth muscle tumors is similar to that noted previously. 4 ficient in revealing the correct diagnosis. The mitotic About 50% of the leiomyosarcomas had metastasized rate was particularly effective in classifying hyperplas-at the time of surgery, whereas the diagnosis of other tic lesions (100% sensitivity) but was less accurate in tumors was made on the basis of cellular morphology determining malignancy (70% specificity). or invasion. Our data suggest that both AgNOR counts and mitotic indexes are capable of differentiating benign from malignant smooth muscle tumors.
Transitional cell carcinomas comprise 70-80% of all epithelial neoplasms in the bladder. 12, 16 However, polypoid cystitis 11 can easily be mistaken for this tumor in maloriented or small surgical specimens. As in other case series, older female dogs predominated in the transitional cell carcinoma group, 12 and younger male dogs dominated the patient group with cystitis. AgNORs were not useful in separating canine hyperplastic inflammatory lesions from carcinoma under the conditions of this study. The stain has been successful in classifying human hyperplastic and neoplastic, urinary bladder lesions, 9, 14, 19 although not uniformly. 15 Several of these studies used computer-assisted image analysis, possibly with less error than direct observation. Two reasons were apparent for the difficulty in relying on AgNOR counts to separate urinary tract specimens by diagnosis. One reason was the heterogeneity in the various tumors, which may reflect true variability among tumor cells. When lectin binding pattern was used to indicate malignant behavior, transitional cell carcinomas showed considerable variation, 23 suggesting that neoplastic cells may be heterogeneous in their transformed phenotype. A second source of variation was the high concentration of AgNORs per nucleus in some inflamed specimens. Given the relative separation of the 2 conditions on the basis of mitotic index, it ap-pears that AgNOR number may increase in inflammatory conditions of the canine urinary bladder without associated increase in mitotic activity. AgNOR staining is simple and reproducible under conditions of specimen submission prevalent in our laboratory. Most specimens were fixed for a relatively short period during mailing or submission by courier, so that the fixation interval was probably no more than 7 days. Only 1 specimen had to be eliminated from the study because of excessive staining artifact. Use of a green filter was helpful in increasing contrast between the NORs and the remainder of the cell, and with this technique single observer variation was low (about 12% for all smooth muscle tumors) between multiple examinations carried out on the same tissue. Reduced staining intensity has been noticed in the AgNORstained specimens over time; however, recently developed modifications to the procedure 13 may correct this defect.
To be successfully enumerated, mitoses must be counted in a standardized manner. 22 Criteria for mitotic figures include the absence of a nuclear membrane, presence of well-defined hairy extensions of the nuclear material, and the counting of 2 parallel, clearly separate chromosome clots as 2 mitoses, even if it is clear that they arise from a single dividing cell. Using these standards, the correlation coefficient averaged 0.91 among multiple observers. 22 The use of 1 observer to determine mitotic indexes may have resulted in an underestimate of variability, which might have been more accurately determined if multiple observers had been used, artificially increasing the efficiency of mitotic index in separating various groups of specimens.
Interobserver variation in determining AgNORs in smooth muscle tumors was great and may be attributed to a variety of factors. One source of variation lies in enumerating extranucleolar AgNORs, which may appear as clustered dots within the nucleoplasm rather than as well-defined structures. 7 Variation in fixation may further decrease the size of these AgNORs, 8 compounding the difficulty in differentiating these structures from clusters of cell debris. Another source of variability, both among observers and among specimens, is nuclear orientation. Recent work indicates that AgNORs are more accurately measured in cytologic preparations than in histologic specimens because the entire nucleus of each cell is visible, rather than having sections at an angle to the nuclear axis. 6 AgNORs have been useful in a variety of situations to separate lesions according to the probability of their recurrence or metastasis. In some neoplasms, increased AgNOR expression correlates with increased K167 6 expression and hence with mitotic activity, whereas in others AgNOR expression may also be correlated with aneuploidy. 6, 10, 15 In neuroblastomas, in which diploid rather than aneuploid chromosome number is associated with poor prognosis, AgNOR numbers increase with decreased patient survival. 5 This finding indicates that AgNORs need not be associated with excessive chromosome numbers to be useful in forecasting prognosis but can also increase as a result of binding of argyrophilic proteins to additional transcription sites in the genome. Aneuploidy is prevalent in human transitional cell carcinomas, 20 but we do not know the chromosome complement of any of the neoplasms in our study. Both factors may contribute to variation in AgNOR counts.
